Get started
Author

Tsukasa Iwakura

Observed name: IWAKURA, Tsukasa
Observed institution: Kawasaki Medical School
OpenAlex ID: A5025918537
Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis
2023 · Hiroyuki Kadoya, Akira Hirano, et al. · The FASEB Journal · 13
PDF
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases
2026 · Brendon L. Neuen, Vlado Perkovic, et al. · JAMA · 9
PDF
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice
2024 · Eriko Kajimoto, Hajime Nagasu, et al. · Scientific Reports · 7
PDF
Effects of Beraprost on Intestinal Microcirculation and Barrier Function in a Mouse Model of Renal Failure
2024 · Akira Hirano, Hiroyuki Kadoya, et al. · Microcirculation · 4
Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease
2026 · Tsukasa Iwakura, Kengo Kidokoro, et al. · Hypertension · 3
Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages
2025 · Masanobu Takasu, Seiji Kishi, et al. · American Journal of Physiology-Renal Physiology · 2
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis
2026 · Hiddo J L. Heerspink, Jelle M Beernink, et al. · European Heart Journal
PDF
Wcn26-6348 Protective Role of Finerenone Against Podocyte Injury Through Mr–trpc Pathway Inhibition in Diabetic Kidney Disease
2026 · Tsukasa Iwakura, Kengo Kidokoro, et al. · Kidney International Reports
WCN26-3563 The Mineralocorticoid Receptor–TRPC5 pathway Drives Macrophage-Mediated Inflammation in Diabetic Kidney Disease
2026 · Masafumi Wada, Hajime Nagasu, et al. · Kidney International Reports
WCN26-2876 Effects of Non-steroidal Mineralocorticoid Receptor Blocker Esaxerenone on Glomerular Hemodynamics in type 2 Diabetic Kidney Disease
2026 · Rie Tatsugawa, Kengo Kidokoro, et al. · Kidney International Reports
PDF
Elucidation of the Molecular Mechanism of Albuminuria Improvement by Nonsteroidal Mineralocorticoid Receptor (MR) Antagonists Focusing on Podocyte Calcium (Ca2+) Dynamics
2023 · Tsukasa Iwakura, Kengo Kidokoro, et al. · Journal of the American Society of Nephrology
Ps-b09-3: Examination of Albuminuria Reduction Effect Through Improvement of Enos Uncoupling by Sglt2 in Type 2 Diabetic Mice
2023 · Tsukasa Iwakura, Megumi Kondo, et al. · Journal of Hypertension
The deficient of eNOS-NO pathway exacerbates kidney dysfunction via inflammasome activation in diabetic kidney disease
2023 · UMENO, Reina, NAGASU, Hajime, et al. · Institutional Repositories DataBase (IRDB)
Works count: 12
Citation count: 38
H-index: 4
I10-index: 1
Year
Topic
Type